News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Receptor BioLogix, Inc. Names Four New Senior Executives



12/15/2006 10:55:26 AM

SOUTH SAN FRANCISCO, Calif., Dec. 15 /PRNewswire/ -- Receptor BioLogix, Inc., a biopharmaceutical company focused on developing a newly discovered class of protein therapeutics to treat cancer and other diseases, today announced the following individuals have joined the company's management team: Janet I. Swearson was named chief financial officer; Guy M. Gammon, M.B., B.S. (M.D.), M.R.C.P., was appointed chief medical officer; Douglas J. Kawahara, Ph.D., was named vice president of business development, and David Lilienfeld, M.D., M.P.H., was appointed senior director, regulatory and clinical affairs.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES